Cargando…
ENDOBRONCHIAL TISSUE PLASMINOGEN ACTIVATOR (TPA) ADMINISTRATION TO RESOLVE ENDOBRONCHIAL OBSTRUCTION DUE TO SIGNIFICANT BLOOD CLOT BURDEN IN A SAR COV 2 POSITIVE PATIENT ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
Autores principales: | LANDA, ELISE, FARRA, WASEEM, EHTESHAM, MUHAMMAD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503486/ http://dx.doi.org/10.1016/j.chest.2021.07.641 |
Ejemplares similares
-
Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model
por: Cardenes, Nayra, et al.
Publicado: (2019) -
BLOODSTREAM INFECTIONS IN PATIENTS WITH COVID-19 TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
por: SHARAYAH, AHMAD, et al.
Publicado: (2022) -
Posthospitalization outcomes after extracorporeal membrane oxygenation (ECMO) for COVID-19
por: Gribensk, Arthur, et al.
Publicado: (2022) -
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) VS CONVENTIONAL MECHANICAL VENTILATION FOR SEVERE ACUTE RESPIRATORY FAILURE DUE TO COVID-19: A MULTICENTER MATCHED COHORT STUDY
por: WHITMORE, SAGE, et al.
Publicado: (2022) -
RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COVID-19 REQUIRING ECMO IS PREDICTIVE OF LONGER ECMO COURSE BUT NOT INCREASED MORTALITY
por: TAYLOR, LAUREN, et al.
Publicado: (2021)